FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

49722008: Somatostatin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
82812011 Somatotropin release inhibiting factor en Synonym Active Entire term case insensitive SNOMED CT core module
82813018 Somatostatin en Synonym Active Entire term case insensitive SNOMED CT core module
82814012 Growth hormone inhibiting factor en Synonym Active Entire term case insensitive SNOMED CT core module
787432017 Somatostatin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1230764012 Growth hormone release inhibiting hormone en Synonym Active Entire term case insensitive SNOMED CT core module
1230765013 SS - Somatostatin en Synonym Active Entire term case sensitive SNOMED CT core module
2670919019 Somatostatin-14 en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Somatostatin Is a Gastrointestinal hormone true Inferred relationship Existential restriction modifier
Somatostatin Is a Substance with hypothalamic inhibiting factor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Somatostatin Is a Peptide hormones and their metabolites and precursors false Inferred relationship Existential restriction modifier
Somatostatin Has disposition Hypothalamic inhibiting factor true Inferred relationship Existential restriction modifier
Somatostatin Is a Peptide hormone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Octreotide Is a False Somatostatin Inferred relationship Existential restriction modifier
Somatostatin-14 Is a False Somatostatin Inferred relationship Existential restriction modifier
Somatostatin-28 Is a False Somatostatin Inferred relationship Existential restriction modifier
Somatostatin measurement Has measured component False Somatostatin Inferred relationship Existential restriction modifier
Somatostatin antigen Direct substance False Somatostatin Inferred relationship Existential restriction modifier
Serum somatostatin measurement Has measured component False Somatostatin Inferred relationship Existential restriction modifier
Somatostatin measurement Component True Somatostatin Inferred relationship Existential restriction modifier 1
Serum somatostatin measurement Component True Somatostatin Inferred relationship Existential restriction modifier 2
Lanreotide 30mg powder and solvent for injection suspension vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Lanreotide acetate 38mg injection Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Plasma somatostatin level Component True Somatostatin Inferred relationship Existential restriction modifier 2
Product containing somatostatin Has active ingredient True Somatostatin Inferred relationship Existential restriction modifier 1
Product containing somatostatin analog Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 50micrograms/mL injection solution 1mL ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 100micrograms/mL injection solution 1mL ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 500micrograms/mL injection solution 1mL ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 200micrograms/mL injection solution 5mL vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for injection suspension vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Product containing lanreotide Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Product containing octreotide Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate preparation Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.3mL prefilled syringe Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.3mL prefilled syringe Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Lanreotide 120mg/0.5mL prefilled syringe Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 20mg depot injection Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 10mg depot injection Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 30mg depot injection Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 1mg/mL injection solution ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 100mcg/mL injection solution ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 200mcg/mL injection solution ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 500mcg/mL injection solution ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide acetate 50mcg/mL injection solution ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Lanreotide acetate 30mg/vial injection suspension Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 1mg/mL injection solution ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 1mg/mL injection solution ampule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Product containing octreotide Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for injection suspension vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Product containing somatostatin analog Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Somatostatin acetate Is a False Somatostatin Inferred relationship Existential restriction modifier
Somatostatin acetate Is modification of True Somatostatin Inferred relationship Existential restriction modifier
Somatostatin-28 Is modification of True Somatostatin Inferred relationship Existential restriction modifier
Product containing only somatostatin (medicinal product) Has active ingredient True Somatostatin Inferred relationship Existential restriction modifier 1
Substance concentration of somatostatin in plasma (observable entity) Component True Somatostatin Inferred relationship Existential restriction modifier 1
Substance concentration of somatostatin in serum (observable entity) Component True Somatostatin Inferred relationship Existential restriction modifier 1
Lanreotide 30mg injection (pdr)+diluent+syringe - product Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Somatuline LA 30mg injection (pdr)+diluent+syringe Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) 1 vial Has active ingredient False Somatostatin Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start